Vancomycin-resistant Staphylococcus aureus: Difference between revisions
Hardik Patel (talk | contribs) No edit summary |
Hardik Patel (talk | contribs) |
||
Line 15: | Line 15: | ||
==[[Vancomycin-resistant Staphylococcus aureus causes|Causes]]== | ==[[Vancomycin-resistant Staphylococcus aureus causes|Causes]]== | ||
==[[Vancomycin-resistant Staphylococcus aureus epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Vancomycin-resistant Staphylococcus aureus epidemiology and demographics|Epidemiology and Demographics]]== |
Revision as of 16:42, 17 December 2012
For patient information click here
Vancomycin-resistant Staphylococcus aureus Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Vancomycin-resistant Staphylococcus aureus On the Web |
American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus |
Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus |
Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: VRSA; VISA; vancomycin-intermediate Staphylococcus aureus
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | EKG | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies